Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance.
abscopal effect
adrenergic signaling
chronic stress
immunosuppression
radiation therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
20 Dec 2020
20 Dec 2020
Historique:
received:
13
11
2020
revised:
15
12
2020
accepted:
16
12
2020
entrez:
9
1
2021
pubmed:
10
1
2021
medline:
10
1
2021
Statut:
epublish
Résumé
Ionizing radiation has been used in the treatment of cancer for more than 100 years. While often very effective, there is still a great effort in place to improve the efficacy of radiation therapy for controlling the progression and recurrence of tumors. Recent research has revealed the close interaction between nerves and tumor progression, especially nerves of the autonomic nervous system that are activated by a variety of stressful stimuli including anxiety, pain, sleep loss or depression, each of which is likely to be increased in cancer patients. A growing literature now points to a negative effect of chronic stressful stimuli in tumor progression. In this review article, we present data on the potential for adrenergic stress to influence the efficacy of radiation and in particular, its potential to influence the anti-tumor immune response, and the frequency of an "abscopal effect" or the shrinkage of tumors which are outside an irradiated field. We conclude that chronic stress can be a major impediment to more effective radiation therapy through mechanisms involving immunosuppression and increased resistance to radiation-induced tumor cell death. Overall, these data highlight the potential value of stress reduction strategies to improve the outcome of radiation therapy. At the same time, objective biomarkers that can accurately and objectively reflect the degree of stress in patients over prolonged periods of time, and whether it is influencing immunosuppression and radiation resistance, are also critically needed.
Identifiants
pubmed: 33419318
pii: cancers12123853
doi: 10.3390/cancers12123853
pmc: PMC7767049
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : P30 CA016056
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA099326
Pays : United States
Organisme : National Cancer Institute, Cairo University
ID : P30CA016056
Organisme : NCI NIH HHS
ID : R01 CA236390
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA205246
Pays : United States
Organisme : NIH HHS
ID : R01 CA236390, R01 CA099326, R01 CA205246
Pays : United States
Références
Endocr Rev. 2000 Feb;21(1):55-89
pubmed: 10696570
Oncotarget. 2017 Jan 24;8(4):6446-6460
pubmed: 28031536
Curr Neuropharmacol. 2016;14(7):665-73
pubmed: 27640517
Lancet Oncol. 2009 Jul;10(7):718-26
pubmed: 19573801
Oncol Rep. 2011 May;25(5):1439-46
pubmed: 21380491
Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):869-76
pubmed: 21345609
Immunol Rev. 2006 Oct;213:131-45
pubmed: 16972901
Oxid Med Cell Longev. 2019 Nov 13;2019:1270397
pubmed: 31814865
PLoS One. 2011 Apr 29;6(4):e19246
pubmed: 21559428
Cancers (Basel). 2019 Jan 18;11(1):
pubmed: 30669417
Nat Rev Cancer. 2020 Mar;20(3):143-157
pubmed: 31974491
J Clin Oncol. 2016 Mar 20;34(9):980-6
pubmed: 26811521
Cureus. 2019 Feb 20;11(2):e4103
pubmed: 31057997
Psychol Bull. 2004 Jul;130(4):601-30
pubmed: 15250815
Sci Rep. 2017 Oct 11;7(1):12964
pubmed: 29021585
Expert Opin Investig Drugs. 2016;25(5):501-5
pubmed: 26954371
Health Qual Life Outcomes. 2013 Jul 17;11:121
pubmed: 23866850
J Clin Invest. 2019 Mar 1;129(3):1030-1046
pubmed: 30688660
Front Oncol. 2020 Jan 08;9:1381
pubmed: 31970082
Cancer Res. 2004 Nov 1;64(21):7879-85
pubmed: 15520194
Curr Opin Pharmacol. 2013 Apr;13(2):265-73
pubmed: 23294896
J Immunother Cancer. 2016 May 17;4:29
pubmed: 27190630
Gastroenterology. 2016 Jun;150(7):1659-1672.e5
pubmed: 26946344
J Cogn Neurosci. 2013 Nov;25(11):1896-907
pubmed: 23806175
Nat Clin Pract Oncol. 2008 Aug;5(8):466-75
pubmed: 18493231
Cancer. 2014 Jan 15;120(2):302-11
pubmed: 24127333
Sci Adv. 2017 Oct 04;3(10):e1700495
pubmed: 28983508
Eur J Immunol. 2013 Apr;43(4):1001-12
pubmed: 23436577
Clin Cancer Res. 2019 Apr 15;25(8):2621-2632
pubmed: 30504424
Int J Biol Sci. 2015 May 15;11(7):726-36
pubmed: 26078715
Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1769-1784
pubmed: 28723418
Front Oncol. 2020 Aug 19;10:1492
pubmed: 32974180
Breast Cancer Res Treat. 1994 Feb;29(2):141-60
pubmed: 8012033
Cancer Res. 2015 Jun 1;75(11):2232-42
pubmed: 25858148
Annu Rev Immunol. 2014;32:659-702
pubmed: 24655300
Oncogenesis. 2018 Oct 8;7(10):81
pubmed: 30297705
Cells. 2019 Oct 31;8(11):
pubmed: 31683669
Trends Cancer. 2016 Apr;2(4):166-175
pubmed: 28741570
Neuroimmunomodulation. 2000;7(3):160-8
pubmed: 10754404
Front Oncol. 2017 Nov 13;7:269
pubmed: 29181335
Radiother Oncol. 2010 Nov;97(2):258-62
pubmed: 20189668
Br J Cancer. 2000 Dec;83(12):1747-54
pubmed: 11104576
Mol Cancer. 2011 Nov 26;10:146
pubmed: 22118662
Cancer Biol Ther. 2010 Jul 1;10(1):19-29
pubmed: 20424515
J Immunol. 2019 Feb 1;202(3):631-636
pubmed: 30670578
Front Immunol. 2019 Mar 18;10:475
pubmed: 30936876
Indian J Psychol Med. 2018 May-Jun;40(3):232-238
pubmed: 29875530
Brain Behav Immun. 2016 Oct;57:338-346
pubmed: 27485040
Antioxid Redox Signal. 2014 Mar 20;20(9):1447-62
pubmed: 24124731
J Immunol. 2008 Mar 1;180(5):3132-9
pubmed: 18292536
Br J Radiol. 1953 May;26(305):234-41
pubmed: 13042090
Cancer Res. 2017 Oct 15;77(20):5639-5651
pubmed: 28819022
Cancer Immunol Res. 2016 Sep 2;4(9):744-54
pubmed: 27466265
Am J Cancer Res. 2011;1(7):834-44
pubmed: 22016831
J Int Med Res. 2019 Aug;47(8):3818-3830
pubmed: 31187666
Int J Mol Sci. 2015 Mar 11;16(3):5635-65
pubmed: 25768345
J Immunol. 2015 Nov 15;195(10):5045-54
pubmed: 26459348
J Exp Med. 2014 Dec 15;211(13):2583-98
pubmed: 25422496
Front Oncol. 2020 May 13;10:744
pubmed: 32477953
Drug Des Devel Ther. 2018 Mar 28;12:639-645
pubmed: 29636598
Sci Rep. 2016 Apr 15;6:24548
pubmed: 27079168
Oncotarget. 2017 Nov 25;9(1):802-811
pubmed: 29416656
BMC Immunol. 2020 Apr 16;21(1):18
pubmed: 32299365
J Natl Cancer Inst. 1998 Jan 7;90(1):30-6
pubmed: 9428780
Front Physiol. 2013 Jul 17;4:157
pubmed: 23882218
Clin Cancer Res. 2008 Aug 1;14(15):4883-90
pubmed: 18676762
J Clin Oncol. 2008 Apr 20;26(12):2020-6
pubmed: 18421055
Cancers (Basel). 2019 Mar 13;11(3):
pubmed: 30871232
Radiother Oncol. 2020 May;146:126-135
pubmed: 32146258
J Clin Oncol. 2008 Mar 10;26(8):1355-63
pubmed: 18227528
Braz J Med Biol Res. 2017 Oct 2;50(12):e6138
pubmed: 28977119
Br J Cancer. 2005 Apr 25;92(8):1450-8
pubmed: 15812550
Nature. 2003 Jan 30;421(6922):499-506
pubmed: 12556884
J Immunol. 1990 Jul 1;145(1):260-6
pubmed: 2162889
Brain Behav Immun. 2015 Jul;47:24-34
pubmed: 25640603
Am J Epidemiol. 2017 Sep 1;186(5):532-540
pubmed: 28541391
Front Oncol. 2015 Apr 14;5:90
pubmed: 25927031
J Immunol. 2014 Apr 1;192(7):3101-10
pubmed: 24600032
Pharmaceuticals (Basel). 2020 May 26;13(6):
pubmed: 32466499
Neuroimmunomodulation. 2009;16(5):300-17
pubmed: 19571591
Mol Med Rep. 2018 Jun;17(6):8530-8535
pubmed: 29658580
Cell Mol Life Sci. 2010 Feb;67(3):405-17
pubmed: 19862476
Int Immunopharmacol. 2017 May;46:178-185
pubmed: 28314222
Dose Response. 2012 Sep 29;11(3):374-84
pubmed: 23983665
Br J Cancer. 2007 Jul 2;97(1):105-11
pubmed: 17551492
Prev Med. 2017 Mar;96:28-35
pubmed: 27923666
Exp Cell Res. 2015 Dec 10;339(2):163-73
pubmed: 26524508
Front Immunol. 2019 Jan 14;9:3077
pubmed: 30692991
J Clin Invest. 2019 Oct 1;129(10):4224-4238
pubmed: 31483286
Int J Cancer. 2002 Jul 20;100(3):347-54
pubmed: 12115552
Curr Probl Cancer. 2016 Jan-Feb;40(1):10-24
pubmed: 26612692
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):69-92
pubmed: 28249796
Cancers (Basel). 2020 May 13;12(5):
pubmed: 32413989
Clin Lung Cancer. 2015 Mar;16(2):128-36
pubmed: 25450873
Cancer Res. 2006 Sep 1;66(17):8352-5
pubmed: 16951142
Biology (Basel). 2020 Feb 22;9(2):
pubmed: 32098331
J Immunol. 1998 Apr 1;160(7):3251-8
pubmed: 9531281
J Immunol. 2016 Jan 15;196(2):637-44
pubmed: 26663782
Clin Pharmacol Ther. 2011 Mar;89(3):366-78
pubmed: 21289619
Endocr Rev. 2017 Feb 1;38(1):3-45
pubmed: 27749086
N Engl J Med. 2008 Jun 12;358(24):2649-51
pubmed: 18550886
Cancer Immunol Immunother. 2019 Jan;68(1):11-22
pubmed: 30229289
Front Oncol. 2020 Apr 28;10:649
pubmed: 32411607
Clin Cancer Res. 2017 Sep 15;23(18):5514-5526
pubmed: 28533222
Front Oncol. 2015 Jan 12;4:375
pubmed: 25629002
Oncotarget. 2016 Nov 22;7(47):77825-77837
pubmed: 27788481
Health Qual Life Outcomes. 2011 Aug 03;9:62
pubmed: 21812962
Immunotherapy. 2019 Dec;11(17):1445-1461
pubmed: 31826745
Radiat Res. 2019 Jun;191(6):585-589
pubmed: 31021732
Oncol Rep. 2015 Jun;33(6):3099-107
pubmed: 25872592
J Exp Med. 2016 Nov 14;213(12):2567-2574
pubmed: 27799619
Nature. 2019 Oct;574(7776):45-56
pubmed: 31578484
J Nucl Med. 2014 Mar;55(3):439-45
pubmed: 24504055
Am J Cancer Res. 2014 Nov 19;4(6):850-61
pubmed: 25520873
Cell Div. 2013 Jan 03;8(1):1
pubmed: 23286511
Oncotarget. 2016 Oct 18;7(42):68314-68327
pubmed: 27582542
Oncoimmunology. 2017 Dec 21;7(3):e1405205
pubmed: 29399407
Nat Rev Cancer. 2009 Feb;9(2):134-42
pubmed: 19148183
Cancer Res. 2011 Apr 1;71(7):2488-96
pubmed: 21300764
Cancer Immunol Res. 2013 Oct;1(4):210-6
pubmed: 24490177
Cancers (Basel). 2018 Nov 30;10(12):
pubmed: 30513596
Wien Klin Wochenschr. 2000 Dec 7;112(23):986-94
pubmed: 11190714
Nat Commun. 2017 Jun 09;8:15618
pubmed: 28598415
J Immunol. 2013 Apr 1;190(7):3163-71
pubmed: 23420884
J Cell Physiol. 2016 Feb;231(2):459-72
pubmed: 26189563
Nat Rev Cancer. 2017 Jan 27;17(2):93-115
pubmed: 28127048
Biochim Biophys Acta Mol Cell Res. 2018 Dec;1865(12):1878-1890
pubmed: 30262435
Cancer Res. 1999 Aug 1;59(15):3821-30
pubmed: 10447001
Neuroimmunomodulation. 2000;8(3):154-64
pubmed: 11124582
JCI Insight. 2016 Dec 22;1(21):e90240
pubmed: 28018974
Nat Commun. 2020 Apr 14;11(1):1821
pubmed: 32286326
Medicine (Baltimore). 2016 Dec;95(50):e5529
pubmed: 27977584
G Chir. 2015 May-Jun;36(3):133-6
pubmed: 26188759
J Cell Biol. 2008 May 5;181(3):485-96
pubmed: 18443222
Ecancermedicalscience. 2016 Oct 12;10:680
pubmed: 27899953
Curr Treat Options Neurol. 2007 Sep;9(5):337-46
pubmed: 17716597
Clin Cancer Res. 2009 Sep 1;15(17):5379-88
pubmed: 19706802
Cancer. 2005 Sep 15;104(6):1129-37
pubmed: 16080176
Pediatr Res. 2017 Jul;82(1):155-163
pubmed: 28376078
Vascul Pharmacol. 2010 Nov-Dec;53(5-6):200-8
pubmed: 20732454
Clin Cancer Res. 2021 Jan 1;27(1):87-95
pubmed: 33127652
Nat Commun. 2015 Mar 10;6:6426
pubmed: 25756236
Cell Mol Life Sci. 2016 Aug;73(16):2999-3007
pubmed: 27022944
Melanoma Res. 2017 Oct;27(5):485-491
pubmed: 28858075
Clin Cancer Res. 2018 Jun 1;24(11):2493-2504
pubmed: 29476019
Front Oncol. 2019 Oct 29;9:1077
pubmed: 31737559
J Clin Oncol. 2018 Jun 1;36(16):1611-1618
pubmed: 29437535
Sci Rep. 2018 May 4;8(1):7050
pubmed: 29728578
Int J Cancer. 2006 Jun 1;118(11):2744-9
pubmed: 16381019
Ann Oncol. 2013 May;24(5):1312-9
pubmed: 23300016
Brain Behav Immun. 2019 Aug;80:839-848
pubmed: 31132458
J Hematol Oncol. 2018 Aug 16;11(1):104
pubmed: 30115069
Eur J Cancer. 2002 Jul;38(10):1351-7
pubmed: 12091066
Biomed J. 2019 Jun;42(3):155-165
pubmed: 31466709
Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):49
pubmed: 30263032
Semin Radiat Oncol. 2015 Jan;25(1):18-27
pubmed: 25481262
Pancreatology. 2016 Nov - Dec;16(6):1106-1112
pubmed: 27600995
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):499-507
pubmed: 17398016
J Plast Reconstr Aesthet Surg. 2011 Jun;64(6):759-65
pubmed: 20870476
N Engl J Med. 2012 Mar 8;366(10):925-31
pubmed: 22397654
Anticancer Res. 2005 Jan-Feb;25(1B):531-6
pubmed: 15816624
Ann Oncol. 2020 Jan;31(1):96-102
pubmed: 31912803
Cancer Biol Ther. 2017 Jan 2;18(1):36-42
pubmed: 27905824
J Clin Invest. 2019 Dec 2;129(12):5537-5552
pubmed: 31566578
Oncoscience. 2017 Aug 23;4(7-8):95-105
pubmed: 28966942
PLoS One. 2012;7(12):e50946
pubmed: 23284651
Radiat Oncol. 2019 Jan 30;14(1):23
pubmed: 30700317
J Altern Complement Med. 2010 May;16(5):531-8
pubmed: 20455784
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S33-40
pubmed: 20061006
Clin Exp Immunol. 2005 Jan;139(1):25-34
pubmed: 15606610
Nat Commun. 2017 Nov 23;8(1):1736
pubmed: 29170400
J Clin Immunol. 1987 May;7(3):210-7
pubmed: 3496353
J Hematol Oncol. 2019 Jul 12;12(1):76
pubmed: 31300030
J Immunol. 2016 Apr 15;196(8):3460-9
pubmed: 26969754
Clin Pharmacol Ther. 2020 Sep;108(3):606-615
pubmed: 32418204
J Clin Oncol. 2009 Jun 20;27(18):2970-6
pubmed: 19451440
Front Oncol. 2019 Aug 08;9:745
pubmed: 31440473
EXCLI J. 2017 Jul 21;16:1057-1072
pubmed: 28900385
Clin Sci (Lond). 2005 Nov;109(5):431-7
pubmed: 16232127
Semin Cancer Biol. 2013 Dec;23(6 Pt B):533-42
pubmed: 24012659
Curr Breast Cancer Rep. 2017;9(1):45-51
pubmed: 28344743
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20176-81
pubmed: 24248371
Eur J Cancer. 2016 Oct;66:138-43
pubmed: 27573427
Radiother Oncol. 2016 May;119(2):291-9
pubmed: 26874542
CA Cancer J Clin. 2018 Mar;68(2):153-165
pubmed: 29338071
Future Oncol. 2019 May;15(15):1697-1705
pubmed: 30977688
Head Neck. 2019 Nov;41(11):3924-3932
pubmed: 31435980
BMB Rep. 2015 May;48(5):295-300
pubmed: 25748171
Curr Mol Med. 2013 Jul;13(6):1023-34
pubmed: 23745588
Am J Pathol. 2012 Feb;180(2):862-71
pubmed: 22138581
Brain Behav Immun. 2010 Aug;24(6):952-8
pubmed: 20362661
Blood. 2009 Jul 16;114(3):589-95
pubmed: 19349616
Front Neuroendocrinol. 2018 Apr;49:31-42
pubmed: 29258741
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
BMC Biol. 2017 Feb 14;15(1):13
pubmed: 28196531
Oncoimmunology. 2018 Mar 13;7(7):e1442166
pubmed: 30034949
Future Oncol. 2010 Dec;6(12):1863-81
pubmed: 21142861
J Exp Clin Cancer Res. 2018 Apr 23;37(1):87
pubmed: 29688867
J Clin Invest. 2010 Mar;120(3):694-705
pubmed: 20179352
Cell Metab. 2016 Aug 9;24(2):324-31
pubmed: 27476975
Cancer Res. 2008 Dec 1;68(23):9663-70
pubmed: 19047143
Int J Cancer. 2015 Sep 1;137(5):1147-57
pubmed: 25530021
Oncol Rep. 2009 Oct;22(4):825-30
pubmed: 19724861
Int J Psychiatry Med. 2018 May;53(3):207-220
pubmed: 29292669
J Clin Med. 2019 Apr 26;8(5):
pubmed: 31035526
Ann Surg. 2012 Jul;256(1):146-56
pubmed: 22580939
Radiat Oncol. 2010 Oct 26;5:98
pubmed: 20977754
Cancer Immunol Res. 2013 Dec;1(6):365-72
pubmed: 24563870
Mol Med Rep. 2018 Apr;17(4):5213-5221
pubmed: 29393410
JAMA Otolaryngol Head Neck Surg. 2013 Jan;139(1):14-20
pubmed: 23329087
Int J Cancer. 2019 May 15;144(10):2390-2400
pubmed: 30484859
J Radiat Res. 2016 Jul;57(4):325-35
pubmed: 27242342
Clin Cancer Res. 2020 Apr 15;26(8):1803-1811
pubmed: 31754048
Onco Targets Ther. 2019 Jul 11;12:5499-5513
pubmed: 31371988
Oncotarget. 2017 Feb 21;8(8):14133-14146
pubmed: 27823965
Surgery. 2020 Jul;168(1):167-172
pubmed: 32197785
Cancer. 2018 Sep 15;124(18):3668-3676
pubmed: 30033631
Virchows Arch. 2010 Nov;457(5):521-7
pubmed: 20812018
Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):285-295
pubmed: 31212042
Biochem Pharmacol. 2010 Dec 15;80(12):1904-14
pubmed: 20599771
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1128-35
pubmed: 21093169
Cancer Res. 2013 May 1;73(9):2782-94
pubmed: 23418320
Arch Otolaryngol Head Neck Surg. 2008 Sep;134(9):958-64
pubmed: 18794441
Acta Pharmacol Sin. 2010 Jan;31(1):102-10
pubmed: 20037603
Br J Cancer. 2013 Jun 25;108(12):2485-94
pubmed: 23695022
Nanomedicine (Lond). 2014 Apr;9(5):695-707
pubmed: 24827844
J Neuroimmunol. 2008 Jan;193(1-2):113-9
pubmed: 18037507
J Cancer. 2020 Aug 10;11(20):5900-5910
pubmed: 32922532
PLoS One. 2014 Jan 22;9(1):e85086
pubmed: 24465481
BMC Cancer. 2019 Oct 11;19(1):943
pubmed: 31604468
Oncotarget. 2017 Jan 10;8(2):2874-2889
pubmed: 27926515
Tex Heart Inst J. 1997;24(4):336-42
pubmed: 9456487
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8531-6
pubmed: 23657011
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1306-10
pubmed: 22208977
Cancer Res. 2010 Sep 15;70(18):7042-52
pubmed: 20823155
Brain Behav Immun. 2011 May;25(4):727-35
pubmed: 21277367
Front Pharmacol. 2018 Nov 27;9:1313
pubmed: 30538630
Nat Rev Cancer. 2011 Apr;11(4):239-53
pubmed: 21430696